MARKET

SESN

Sesen Bio, Inc.
SESN
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-4.6308
22.32
4.166
661,349,656.50
CARISMA THERAPEUTICS INC - HAS SUSPENDED ENROLLMENT OF NEW PATIENTS IN ITS PHASE 1 CLINICAL TRIAL FOR CT-0508
Reuters · 07/02 20:39
CARISMA THERAPEUTICS ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS
Reuters · 07/01 11:30
CARISMA THERAPEUTICS INC - IN ADDITION TO THIS PROGRAM, MODERNA HAS NOMINATED FOUR UNDISCLOSED ONCOLOGY RESEARCH TARGETS UNDER COLLABORATION
Reuters · 06/27 20:30
CARISMA THERAPEUTICS INC: INITIAL PHASE 1 DATA EXPECTED BY YEAR-END 2024
Reuters · 06/25 11:30
CARISMA THERAPEUTICS INC - INITIAL DATA EXPECTED BY YEAR-END 2024
Reuters · 05/16 11:30
CARISMA THERAPEUTICS, INC. <CARM.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $8 FROM $9
Reuters · 05/10 10:33
CARISMA THERAPEUTICS INC <CARM.O>: EVERCORE ISI CUTS TARGET PRICE TO $4 FROM $12
Reuters · 05/10 10:27
CARISMA THERAPEUTICS APPOINTS DR. EUGENE P. KENNEDY AS CHIEF MEDICAL OFFICER
Reuters · 05/02 11:30
More

Webull offers Sesen Bio, Inc. stock information, including NASDAQ: SESN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SESN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SESN stock methods without spending real money on the virtual paper trading platform.